Andreas Halvorsen - Viking Global Investors
Holding/activity history for Zentalis Pharmaceuticals Inc (ZNTL)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2022 Q3 | 0 | 0.00 | Sell 100.00% | 0.26 | SEC | ||
| 2022 Q2 | 2,026,656 | 0.26 | $28.10 | $56,949,000 | SEC | ||
| 2022 Q1 | 2,026,656 | 0.38 | Reduce 4.33% | 0.02 | $46.14 | $93,510,000 | SEC |
| 2021 Q4 | 2,118,284 | 0.52 | $84.06 | $178,063,000 | SEC | ||
| 2021 Q3 | 2,118,284 | 0.39 | Reduce 11.71% | 0.05 | $66.64 | $141,162,000 | SEC |
| 2021 Q2 | 2,399,284 | 0.39 | $53.20 | $127,642,000 | SEC | ||
| 2021 Q1 | 2,399,284 | 0.31 | Reduce 20.32% | 0.09 | $43.39 | $104,105,000 | SEC |
| 2020 Q4 | 3,011,284 | 0.43 | Reduce 32.23% | 0.17 | $51.94 | $156,406,000 | SEC |
| 2020 Q3 | 4,443,284 | 0.53 | $32.69 | $145,251,000 | SEC | ||
| 2020 Q2 | 4,443,284 | 0.92 | Buy | 0.92 | $48.02 | $213,366,000 | SEC |